Merck KGaA reported a 16.6% decline in contract manufacturing due to an unrepeated Covid-19 contract, though overall life ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Merck & Co. has struck a licensing deal with LaNova Medicines that is potentially worth more than $3 billion to the clinical-stage biotechnology company.

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

(Reuters) -Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, ...

Our Life Sciences Masters™ 2024 program will focus on the intersection of intellectual property and the biopharmaceutical industry. With topics covering the innovation ecosystem, the PTO ...

I had a science background, and there was a crime lab opening ... A job with a low stress level, good work-life balance and solid prospects to improve, get promoted and earn a higher salary ...

Switching from a science background to a business one is a journey ... which is what I wanted to do throughout my university life." Despite the increasing opportunities in business, it may not ...

Life coach and author Brooke DeBoer stopped by Sunrise to speak with Natalie Sirna about her mission of offering guidance, compassion, and a wealth of wisdom to help others break free from the chains ...

A key panel of US health advisers voted in favor of lowering the age recommendation for vaccines made by Pfizer Inc. and Merck & Co. that protect against pneumococcal disease, clearing a path for ...